Literature DB >> 6491696

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

G M Clark, C K Osborne, W L McGuire.   

Abstract

The relationships between estrogen receptor, progesterone receptor, and a variety of patient characteristics are described for 2,977 women with primary breast cancer. Older women were more likely to be estrogen-receptor positive than younger women. When patient age and menopausal status were analyzed together, age was found to be the primary determinant of increased estrogen-receptor concentrations. There appeared to be no relationship with progesterone receptor for either age or menopausal status when these variables were analyzed separately. But premenopausal women had higher progesterone receptor concentrations than postmenopausal women when patients of the same age were compared, perhaps reflecting greater estrogen-mediated synthesis of progesterone receptor. Tumor size was negatively related to steroid receptor concentrations, but no relationships were observed between steroid receptors and either the number of positive axillary lymph nodes or the location of the primary tumor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491696     DOI: 10.1200/JCO.1984.2.10.1102

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  90 in total

1.  Some applications of pharmacogenomics and epigenetics in drug development and use in pursuit of personalized medicine.

Authors:  M C Powanda; E D Moyer
Journal:  Inflammopharmacology       Date:  2012-07-07       Impact factor: 4.473

Review 2.  The changing role of ER in endocrine resistance.

Authors:  Agostina Nardone; Carmine De Angelis; Meghana V Trivedi; C Kent Osborne; Rachel Schiff
Journal:  Breast       Date:  2015-08-10       Impact factor: 4.380

3.  CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.

Authors:  Mariam Al-Dhaheri; Jiacai Wu; Georgios P Skliris; Jun Li; Ken Higashimato; Yidan Wang; Kevin P White; Paul Lambert; Yuerong Zhu; Leigh Murphy; Wei Xu
Journal:  Cancer Res       Date:  2011-01-31       Impact factor: 12.701

4.  Ginkgetin induces cell death in breast cancer cells via downregulation of the estrogen receptor.

Authors:  Yoonhwa Park; Sang Hyeok Woo; Sung-Keum Seo; Hyunggee Kim; Woo Chul Noh; Jin Kyung Lee; Byoung-Mog Kwon; Kyung Nam Min; Tae-Boo Choe; In-Chul Park
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

Review 5.  Mammographic screening in older women. Is it worthwhile?

Authors:  J A van Dijck; M J Broeders; A L Verbeek
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

6.  Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance.

Authors:  Gladys Morrison; Xiaoyong Fu; Martin Shea; Sarmistha Nanda; Mario Giuliano; Tao Wang; Teresa Klinowska; C Kent Osborne; Mothaffar F Rimawi; Rachel Schiff
Journal:  Breast Cancer Res Treat       Date:  2014-02-20       Impact factor: 4.872

7.  Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy.

Authors:  A Vering; A Vockel; M Stegmüller; H G Bender
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  An immunohistological study of breast cancer--with special reference to the expression of carbohydrate antigens and estrogen receptor status.

Authors:  M Sowa; Y S Chung; Y Kato; M Nishimura; T Kubo; H Maekawa; Y Fujimoto; K Umeyama; M Kawahara
Journal:  Jpn J Surg       Date:  1990-05

9.  Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.

Authors:  Mothaffar F Rimawi; Priya B Shetty; Heidi L Weiss; Rachel Schiff; C Kent Osborne; Gary C Chamness; Richard M Elledge
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

10.  Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.

Authors:  M Stierer; H Rosen; R Weber; H Hanak; J Spona; H Tüchler
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.